Company Filing History:
Years Active: 1983-1984
Title: Howard J Rytting: Innovator in Drug Delivery Systems
Introduction
Howard J Rytting is a notable inventor based in Lawrence, KS (US). He has made significant contributions to the field of drug delivery systems, particularly focusing on enhancing the absorption rates of rectally administered drugs. With a total of 2 patents to his name, Rytting's work has the potential to improve therapeutic outcomes for patients.
Latest Patents
Rytting's latest patents include innovative methods and drug forms aimed at enhancing the rate of absorption of drugs administered rectally. One of his patents describes a method for preparing a drug form that includes a therapeutically effective unit dosage amount of a selected drug capable of being absorbed into the bloodstream from the rectal compartment. This drug form also incorporates hydroxy aryl or hydroxy aralkyl acids or their derivatives, which are present in sufficient amounts to effectively enhance the drug absorption rate when administered to warm-blooded animals. Another patent focuses on a similar approach but specifically addresses the use of β-lactam drug forms for rectal delivery, further emphasizing the versatility and applicability of his research.
Career Highlights
Rytting is currently associated with Merck & Company, Inc., where he continues to advance his research in drug delivery systems. His work is characterized by a commitment to improving patient care through innovative pharmaceutical solutions.
Collaborations
Rytting has collaborated with esteemed colleagues such as Takeru Higuchi and Toshiaki Nishihata, contributing to a rich exchange of ideas and expertise in the field of drug delivery.
Conclusion
Howard J Rytting's contributions to the field of drug delivery systems exemplify the impact of innovative thinking in pharmaceuticals. His patents not only enhance the understanding of drug absorption but also pave the way for improved therapeutic strategies.